baber/WOPTO huggingface dataset:
Patent IE-853043-L (IE)
Title: A fuel additive composition¹¹group consisting of gasoline and diesel fuel comprising a¹solution of a fuel-soluble platinum group metal coordination¹compound
IPC: A46B9/06
Filed: 1985-12-03
Abstract: A gasoline and diesel fuel additive composition comprising solutions of a fuel-soluble platinum group metal compound in a solvent miscible in the diesel, the platinum group metal complex being present in an amount sufficient to supply from 0.01 to 1.0 parts per million of the platinum group metal when added to a predetermined amount of fuel. Preferred solvents are oxygenated hydrocarbons such as ethanol, tetrahydrofuran, and methyl tertiary butyl ether, and will preferably be employed in amounts of less than 5% of the weight of the gasoline to provide oxygen and the metal at a weight ratio of from 1,000:1 to 100,000:1. Especially preferred compounds are those of formula (I), wherein M is a platinum group metal and R is benzyl, phenyl or nitrobenzyl. The additive compositions and fuel treated therewith improve operating efficiency of internal combustion engines in terms of increased power output per unit of fuel burned and reduce the emissions of particulates and noxious gases such as carbon monoxide and nitrogen monoxide . The additives provide beneficial results upon immediate use and over long periods of continuous use.
[GB2178757A]
Patent IE-873212-L (IE)
Title: Medicaments based on derivatives of 3,4-di-phenylpiperidine,¹the use of the derivatives as medicaments, and novel¹3,4-diphenylpiperidine derivatives and a process for the¹preparation therefor
IPC: A61K31/451
Filed: 1987-11-26
Abstract: Medicines containing a 3,4-diphenylpiperidine derivative of the formula Ia <IMAGE> in which X, Y and n have the meanings given, or a physiologically tolerable salt of these compounds and their use as antidepressant are described. 3,4-Diphenylpiperidine derivatives of the formula I <IMAGE> in which X, Y and n have the meanings given, and their physiologically tolerable salts and processes for their preparation are additionally described.
[EP0273199A2]
Patent NO-840846-L (NO)
Inventor: SCHAEFER KARL
IPC: B27L11/02
Filed: 1984-03-06
Abstract: Method for the manufacture of flakes from chips and apparatus for carrying out the method. The worn, in use, blade portions of a strip-steel knife are exchanged continuously or periodically with sharp strip-steel knives during the flake manufacturing operation. The feed of the strip-steel knives is preferably time-dependent and/or dependent on the energy consumption of the apparatus. Disposed longitudinally of the knife-ring are one or several magazines for supplying or/and receiving the strip-steel knives.
Patent NO-882460-L (NO)
Inventor: SMITH GEOFFREY WILLIAM
IPC: D06M101/34
Filed: 1988-06-03
Abstract: A process for flame retarding blends of cellulosic and other fibres eg. polyester fibres involves impregnation thereof with tetra kis (hydroxyorgano) phosphonium compounds or condensates thereof followed by curing with ammonia, the operation being performed in at least two steps, and with 5-20% of organophosphorus compound (as THP<+> ion) applied in the first step.
Patent NO-883286-L (NO)
Inventor: BECK GERHARD
IPC: C07D213/30
Filed: 1988-07-22
Abstract: Leukotriene antagonists, processes for the preparation thereof, the use thereof for the treatment of diseases, and precursors. Compounds of the formula I    <IMAGE>  (I)  in which R1, R2, R3, R4, R5, R6 and X have the indicated meanings, processes for the preparation of these compounds, the use thereof as pharmaceuticals, and pharmaceutical products based on these compounds are described. In addition, precursors for the preparation of compounds of the formula I are described.
Patent NO-892229-L (NO)
Inventor: HEAFIELD JOANNE
IPC: A61K31/52
Filed: 1989-06-01
Abstract: A controlled release, solid, oral dosage form containing a 3-alkylxanthine, preferably theophylline, at least one hydrophilic or hydrophobic polymer, at least one wax having a melting point between 25 DEG  and 90 DEG C and between 3% and 10% (by weight) water. Preferably the dosage form is a tablet and the water content is between 4% and 9% (by weight). The amount of water present in the dosage form determines the rate of release of the 3-alkylxanthine.
Patent NO-892592-L (NO)
Inventor: WENDEL WOLFGANG
IPC: H03H7/48
Filed: 1989-06-22
Abstract: In known directional coupler-distributors for the wide-band coupling-out of a part of the radio-frequency signal energy transmitted via a main line, which consist of at least two cascaded single distributors, at least one of which is constructed in directional coupler technique with a current and a voltage transformer and an internal terminating resistor (R) which is connected to earth at one end, branch attenuations of </= 13 dB cannot be achieved or only to a slight extent and with considerable circuit expenditure with adequate decoupling of the output (A) from the branch connection (AB) and good values for transmission loss and return losses. To avoid these disadvantages in as simple and inexpensive a manner as possible, it is provided in accordance with the invention that the internal terminating resistor of each directional-coupler single distributor be formed by its branch impedance by connecting its branch connection (2, 35) to that of the immediately preceding single distributor, that the branch of the last directional coupler single distributor is the only branch connection (AB) and that all currents coupled out of the current transformers (Ü1, Ü2, Ü4) have at least approximately the same phase.
Patent NO-894249-L (NO)
Inventor: SIMPSON JOHN MCLEAN
IPC: C12P21/02
Filed: 1989-10-25
Abstract: Chromatographic methods for the purification of growth hormone-like materials which significantly reduce the aggregate level of the material are disclosed. The methods provide a much more efficient and inexpensive alternative to present techniques used to reduce aggregate impurities.
Patent NO-895167-L (NO)
Inventor: BRIZZOLARA NANCY SUSAN
IPC: A61K9/26
Filed: 1989-12-21
Abstract: Oral compositions for the local administration of a therapeutic agent to a periodontal pocket of a patient for alleviating dental disease comprise a plurality of dry, discrete microparticles each of which comprise an effective amount of at least one therapeutic agent dispersed in a matrix comprising a biocompatible and biodegradable polymer. Apparatus and methods are also provided for the dispensing of the dry microparticles to the periodontal pocket whereby they become tacky and adhere to the involved tissue so as to induce long term therapeutic benefits.
Patent NO-903865-L (NO)
Inventor: BURNOUF-RADOSEVICH MIRYANA
IPC: A61K35/16
Filed: 1990-09-05
Abstract: The invention relates to a process for the preparation of a concentrate of factor VIII-von Willebrand factor complex having high specific activity from whole plasma (not cryoprecipitate). The process comprises a prepurification by a double treatment with barium chloride and aluminium hydroxide. The process then comprises a purification by chromatography on an anion exchange resin of the DEAE-Fractogel type. The process comprises a step of viral inactivation by a solvent/detergent treatment. The process also enables fibrinogen, albumin, immunoglobulins, antithrombin III, fibronectin and prothrombin complex to be recovered from the same plasma. The various concentrates obtained by the process of the invention are intended, in particular, for therapeutic use.
Patent NO-914204-L (NO)
Inventor: RUSKE MANFRED
IPC: D06P1/08
Filed: 1991-10-25
Abstract: Biscationic azo dyes of the formula <IMAGE>  in which     R<1> denotes hydrogen or optionally substituted C1-C5-alkyl,   R<2> denotes hydrogen or C1-C5-alkyl R<3> and R<4> independently of one another denote hydrogen or methyl,   D denotes the radical of a diazo component, optionally substituted phenylene or a radical of the formula <IMAGE> in which Z represents a bridge member, Y denotes hydrogen, C1-C18-alkyl, C2-C6-alkylene, xylidene or phenylene,   An<(-)> denotes the equivalent of an anion,   m denotes 1 or 2 and   n denotes 1 or 2,  with the proviso that   a) when Y denotes hydrogen or C1-C18-alkyl, m represents 2, n represents 1 and D represents optionally substituted 1,4-phenylene or a radical of the formula <IMAGE> and b) when Y denotes C2-C6-alkylene, xylidene or phenylene, m represents 1, n represents 2 and D represents the radical of an aromatic diazo component which is free of sulphonic acid groups, their intermediates and the use of the novel dyes for dyeing or printing polymeric material.
Patent NO-921632-L (NO)
Inventor: GALLAGHER MICHAEL KENRICK
IPC: C08G59/00
Filed: 1992-04-28
Abstract: Epoxy molding compositions for surface mount applications are disclosed. The compositions contain multifunctional epoxy resin and multifunctional hardener along with silicone rubber particles, silicone fluid and a high loading of silica.
Patent NO-922605-L (NO)
Inventor: HAENNINEN JOUNI
IPC: H04W24/00
Filed: 1992-07-01
Abstract: PCT No. PCT/FI91/00328 Sec. 371 Date Jul. 1, 1992 Sec. 102(e) Date Jul. 1, 1992 PCT Filed Oct. 31, 1991 PCT Pub. No. WO92/08299 PCT Pub. Date May 14, 1992.A base station is provided which supervises the quality of a radio link and including a generator circuit for generating a supervising signal having a desired baseband frequency, a measuring circuit for monitoring the level of the baseband supervising signal, and a transmitting circuit for frequency-modulating a transmitting-frequency carrier of said baseband supervising signal. The measuring circuit comprises an A/D converter for deriving digital sample values from the baseband supervising signal, and a control circuit which monitors the deviation of sample values from that of a digital sample value corresponding to a supervising signal level causing a desired deviation in the output signal of the transmitting circuit on the basis of at least one reference value stored in a memory in connection with the calibration so that the deviation is no more than a predetermined difference value.
Patent NO-924862-L (NO)
Title: Fremgangsmaate for fremstilling av karakteristikker til underjordiske formasjoner
Inventor: BLAUCH MATTHEW E
IPC: E21B47/10
Filed: 1992-12-16
Abstract: Det blir beskrevet fremgangsmåter for bestemmelse av stlmuleringsrelaterte karakteristikker til en under- jordisk sone som er gjennomhullet av et borehull før stimulering av sonen. Grunnleggende omfatter metodene injlserlng av liten mengde av et stimuleringsfluid som har et røntgenstrålekontrastmiddel blandet med seg, inn i sonen og så femskaffelse av en eller flere konservert kjerneprøver fra sonen. Kjerneprøvene blir scannet med røntgenstråler og coraputertomografiske bilder blir fremstilt for avgjørelsen av karakteristikken til sonen.
Patent NO-933116-L (NO)
Title: Fremgangsm}te for fremstilling av ost
Inventor: VISZLAI BELA
IPC: A23C9/15
Filed: 1993-09-01
Abstract: Fremgangsmåte for standardisert fremstilling av ost omfattende at melk skummes, den atskilte fløte behandles, fettinnholdet i grunnmelken justeres deretter med den behandlede fløte, melken blir deretter kaldmodnet og dyrket og tilsatt additiver, i visse tilfeller blir melken sammenløpet, der- etter koagulert, opphakket og opp- varmet; mysen separeres og produktet formes, presses, saltes og modnes, hvori størrelsen av fettkuler i melken reduseres til under 2,5 mikron ved be- handling med ultralyd eller ved behand- ling i et Venturi-rør, i en kulemølle og en rørmølle, eller i et forstøvings- apparat. Diameteren av fettkulene redu- seres til 0,6-1,3 mikron. Ultralydbe- handlingen av fløten utføres ved en bølgelengde på 10000-50000 Hz. Varig- heten av ultralydbehandlingen av fløten er opp til 300 sekunder. Den skummende melk pasteuriseres. Tankmelken kald- modnes i 4-10 timer. Sterilisert melk og fløte oppvarmes til en temperatur på 28-40 °C før dyrking.
Patent NO-933260-L (NO)
Inventor: ROURSNELL MICHAEL EDWARD GRIFF
IPC: C12N15/86
Filed: 1993-09-13
Abstract: PCT No. PCT/GB92/00424 Sec. 371 Date Nov. 8, 1993 Sec. 102(e) Date Nov. 8, 1993 PCT Filed Mar. 10, 1992 PCT Pub. No. WO92/16636 PCT Pub. Date Oct. 1, 1992The invention provides a recombinant virus vector for use as an immunotherapeutic or vaccine. The recombinant virus vector comprises at least one pair of nucleotide sequences heterologous to the virus and which have sufficient sequence homology that recombination between them might be expected. The pair of nucleotide sequences are arranged in the virus vector such that they are inverted with respect to each other. The virus vector is able to infect a mammalian host cell and express as polypeptide the heterologous nucleotide sequences in the host cell. For infection thought to be caused by HPV infection, the pair of nucleotide sequences encode part or all of human papillomavirus (HPV) wild-type proteins or mutant proteins immunologically cross-reactive therewith. For an immunotherapeutic or vaccine against cervical cancer, the recombinant virus vector encodes part or all of the HPV wild-type proteins HPV16E7 and HPV18E7 or mutant proteins immunologically cross-reactive therewith.
Patent NO-934196-L (NO)
Title: N,N-disubstituerte arylcykloalkylaminer, deres salter, legemidler inneholdende disse forbindelser, deres anvendelse og fremgangsmåte for deres fremstilling
Inventor: MAIER ROLAND
IPC: C07C211/27
Filed: 1993-11-19
Abstract: Oppfinnelsen angår N,N-disubstituerte arylcykloalkylaminer med den generelle formel hvor n, m, A, X og R1 til R7 er som definert i krav l, deres isomerer, isomerblandinger og deres salter, som oppviser verdifulle egenskaper, spesielt utøver en inhiberende virkning på kolesterolbiosyntesen.
Patent NO-941927-L (NO)
Inventor: MCGEORGE DOUGLAS DONALD
IPC: A61M1/06
Filed: 1994-05-24
Abstract: PCT No. PCT/GB92/02159 Sec. 371 Date May 19, 1994 Sec. 102(e) Date May 19, 1994 PCT Filed Nov. 20, 1992 PCT Pub. No. WO93/11806 PCT Pub. Date Jun. 24, 1993A device incorporating a transparent nipple mold (1) with a sealing flange (2) attached to a valve and syringe port (3). With the device held on the breast, over the nipple areolar complex, air can be withdrawn and the inverted nipple sucked up into the mold (1). Periodic use stretches up the short lactiferous ducts.
Patent NO-943333-L (NO)
Inventor: KIESSLING GERHARD
IPC: B29C35/12
Filed: 1994-09-09
Abstract: A description is given of a fixing method for coils of electrically conductive materials, by impregnating with radically polymerizable compositions and thermal curing, in which the coils are impregnated by dipping, flooding, vacuum impregnating, vacumm pressure impregnating or dripping and are finally cured by high-energy radiation at the same time as or after the thermal curing. The method operates with a low energy requirement and a low emission of volatile substances. Also described are radically polymerizable compositions which can be used for the method.
Patent NO-944659-L (NO)
Title: Laktam-dipeptider med HLE-inhiberende aktivitet
Inventor: VEALE CHRIS ALLAN
IPC: C07K/
Filed: 1994-12-02
Abstract: Foreliggende oppfinnelse vedrører besemte nye amid-deri- vater som er pyrido[3,4-b]indol-2-ylacetamider med formel (I) som er inhibitorer for human leukocytt elastase (HLE), også kjent som human neutrbfil elastase (HNE) som gjør dem anvende- lige når slik inhibering er ønsket, f.eks. forskningsverktøy i farmakologiske, diagnostiske og beslektede studier og ved behandling av sykdommer hos pattedyr hvor HLE inngår. Opp- finnnelsen omfatter også mellomprodukter som kan anvendes ved syntese av disse amid-derivater, fremgangsmåter for fremstil- ling av amid-derivatene, farmasøytiske preparater som innehol- der slike amid-derivater og fremgangsmåter for deres anvendelse.
Patent NO-950061-L (NO)
Title: 4-oksa-1-azabisyklo [3,2,0Å heptan-7-on-derivater som antitumormidler
Inventor: SINGH RAJESHWAR
IPC: A61K31/42
Filed: 1995-01-06
Abstract: Det er beskrevet bruken av 4-oksa-l-azabicyklo-[3,2,0]-heptan-7-on-derivater av formel (I) eller et farmasøytisk akseptabelt salt derav som anti-. tumormidler.hvor R er: -OCOR, hvor R, er et hydrogenatom, en Calkyl-gruppe som kan være substituert med enten én eller to substituenter valgt sammen fra halogenatomer, hydroksy, karboksygrupper eller (3RS,5SR)-(4-oksa-l-azabicyklo-[3,2,0]-heptan-7-on-3-yl)-metyloksy-karbonyl, en.-alkenylgruppe som kan være substituert med karboksygrupper eller (3RS,5SR)-(-oksa-l-azabicyklo-[3,2,0]-heptan-7-on-3-yl)-metyl-oksykarbonyl, en C.-alkynylgruppe, en.cyklo-alkylgruppe som kan være substituert med en karbok-sygruppe eller fenylgruppe som kan ha én, to eller tre substituenter valgt fra gruppen omfattende en cyanogruppe, et halogenatom, karboksylgruppe, C-alkoksygruppe som kan være substituert med en kar-boksygruppe, C,.-alkylgruppe, aminogruppe eller hydroksygruppe; -ORhvor Rj er et hydrogenatom eller benzylgruppe som kan være substituert med én eller to C-alkok-sygrupper, -S(0)Rhvor Rj er en fenylgruppe eller en benzylgruppe som kan være substituert med en C-alkyl-gruppe, n er 0, 1 eller 2,. eller -CHOH.
Patent NO-950996-L (NO)
Inventor: BAENSCH JOHANNES
IPC: C12N1/19
Filed: 1995-03-15
Abstract: Process for producing a source of baker's yeast exhibiting a Lti (Low Temp. Inactive) phenotype, i.e. the property of being practically inactive but surviving in a dough at a temp. ≤ 14 degrees C at which the dough does not freeze, and of being practically inactive at ≤ 18 degrees C in a maltose-contg. medium, in which firstly a strain of haploidal Saccharomyces cerevisiae that is inactive at a temp. of 3-10 degrees C, pref. > 10 degrees C, is crossed with a strain of haploidal Saccharomyces cerevisiae having ≥ 1 MAL allele that is active but with catabolic repression. In a second stage, the segregants are crossed and finally a diploidal prototrophic strain is selected exhibiting a Lti phenotype, an active MAL phenotype that is active but with catabolic suppression, and a potential to be grown in a fed-batch process. Also claimed are Saccharomyces cerevisiae NCIMB 40612 and NCIMB 40611.
Patent NO-951779-L (NO)
Inventor: CHAMPLIN GEORGE B
IPC: F16J15/22
Filed: 1995-05-05
Abstract: A system for reducing packing ring spin and opening up of the joints formed by the ends of a packing ring during break-in of trapezoidally-shaped mechanical braided packing involves utilization of additional warp yarns within the sides of the packing. These additional warp yarns bulge the packing at the sides of the packing above its horizontal centerline such that the outer portion of the packing is provided with a solid rectangular cross section. The solid section increases frictional contact between the rings and the stuffing box and between the rings themselves to eliminate packing ring spin. When the packing is wrapped around a shaft the bulging sides become flat for secure elongated anti-spin contact both between the packing rings and between the end ring and the bottom of the stuffing box. The utilization of the anti-spin configuration eliminates packing ring spin and the opening up of the joints formed by the ends of the packing rings during break-in, regardless of operator error in the installation of the packing rings.
Patent NO-960259-L (NO)
Title: Fremgangsmåte og anordning for merking av beholdere på fastlagt posisjon på beholderne
Inventor: LERUM BJARNE
IPC: B65B35/58
Filed: 1996-01-22
Abstract: Fremgangsmåte og anordning for posisjonering av beholdere (5), hvor den enkelte beholder skal roteres av en rotasjonsenhet (2) med roterende deler (6) inntil et kamera (3) avleser et på forhånd påsatt bilde, etikett eller merke på beholderen, slik at ytterligere merking av beholderen kan foretas.
Patent NO-961861-L (NO)
Title: Anordning ved likeretterkobling
Inventor: RUNDKVIST KJELL
IPC: H02M7/06
Filed: 1996-05-08
Abstract: I et likeretterkoblingsarrangement for oppstarting av en DC-drevet anordning uten forekomst av en. strømrusning, er inngangen i likeretterkoblingen (6) koblet til en enkeltfase-kilde, og en lagerkondensa-tor (7) er koblet over utgangen i likeretterkoblingen. Minst to av de tre inngangsterminalene i likeretterkoblingen (6) er hver seriekoblet til en res-pektiv AC kondensator (9, 10, 11). Hver av kondensatorene (9, 10, 11) er parallellkoblet med en respek-tiv styrt svitsj (12) som virker for å kortslutte kondensatorene (9, 10, 11) etter at lagerkondensa-toren (7) er blitt oppladet.
Patent NO-965475-L (NO)
Inventor: RAULT ISABELLE
IPC: A61P37/08
Filed: 1996-12-19
Abstract: Bioadhesive pharmaceutical composition for the controlled release of active agents in the mouth or via a mucous membrane, comprises one or more vinyl acetate/polyvinylpyrrolidone copolymers (A). The composition is preferably in the form of a matrix and bioadhesion is ensured for up to 24 hours.
Patent NO-975091-L (NO)
Title: Frigj÷rbar flersyklus-forbindelse
Inventor: LEISING LARRY J
IPC: E21B17/06
Filed: 1997-11-04
Abstract: En frigjørbar forbindelse (15) mellom den nedre enden av en settestreng (14) og. et brønnverktøy (11, 12) som er utsatt for å settes fast i en brønn innbefatter indre og ytre deler teleskopisk bevegbare mellom sammentrukkede og forlengede posi-sjoner, en strekkhylse som forbinder delene i den sammenpressede posisjonen og som avbrytes ved et forhåndsbestemt trekk for å tillate teleskopisk bevegelse, en stoppmutter (37) for å begrense slik bevegelse i den utstrukkede posisjonen av delene, og en mekanisme som reagerer på et visst antall av sykluser av teleskopisk bevegelse for udyktiggjøring av stoppmutteren (37) for å tillate fullstendig fri-. gjøring og adskillelse av delene.
Patent NO-981092-L (NO)
Inventor: GOZZINI LUIGIA
IPC: C08G65/329
Filed: 1998-03-12
Abstract: A new class of branched dendrimeric macromolecules, is described essentially consisting of a polyvalent central nucleus and a series of polyoxaalkylene "dendra". Such molecules are characterized by the presence of at least one branch, attached either directly to the "core" or to a "dendron", which does not participate in the growth and which therefore differs from all the other functions of the macromolecule.
Patent NO-985399-L (NO)
Inventor: SCHLOSSNIKL CHRISTIAN
IPC: B29C48/32
Filed: 1998-11-20
Abstract: The invention relates to a device for the production of cellulosic tubular films by extruding a solution of cellulose in an aqueous tertiary amine oxide into a precipitant present below the device, which device comprises an extrusion die having a substantially annular extrusion gap, wherein a supply duct for precipitant and a discharge duct for used precipitant are provided in the interior of the ring formed by the extrusion gap, characterized in that the supply duct (3) for the precipitant terminates below the discharge duct (4) for the used precipitant.
Patent NO-995108-L (NO)
Title: 2-okso-1-azetidinsulfonsyrederivater som potente <beta>-laktamase inhibitorer
Inventor: MAITI SAMARENDRA N
IPC: A61K31/44
Filed: 1999-10-20
Abstract: Oppfinnelsen angår nye 2-okso-l-azetidinsulfonsyrederivater med formel (I) som er verdifulle ved anvendelse i kombinasjon med B-laktam antibiotika for å oke deres effektivitet mot infeksjoner forårsaket av B-laktamase produserende bakterier, l nevnte formel (I) er RI en 5-leddet heterocyklisk ring, særlig thiofen, 2-aminothiazol. R2 er en halvdel som inneholder hydroksypyridon eller N-hydroksypyridon.